Federico Caligaris‐Cappio
- Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research 131
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment 68
- Immunology top 0.2%
- Immunodeficiency and Autoimmune Disorders 62
- Immune Cell Function and Interaction 37
- T-cell and B-cell Immunology 23
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments 21
- Oncology top 1%
- Peptidase Inhibition and Analysis 14
-
- Monoclonal and Polyclonal Antibodies Research 25
- Co-authors
- Paolo GhiaMichael J. KeatingThomas J. KippsMichael HallekEmili MontserratDaniel CatovskyPeter HillmenCristina Scielzo
- Journals
- The Lancet (1 paper)Nucleic Acids Research (1 paper)Journal of Clinical Investigation (3 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Federico Caligaris‐Cappio
207 papers receiving 12.5k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Genetics 8.0k
- Pathology and Forensic Medicine 5.4k
- Immunology 5.8k
- Hematology 2.4k
- Oncology 2.5k
Countries citing papers authored by Federico Caligaris‐Cappio
This map shows the geographic impact of Federico Caligaris‐Cappio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Caligaris‐Cappio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Caligaris‐Cappio more than expected).
Fields of papers citing papers by Federico Caligaris‐Cappio
This network shows the impact of papers produced by Federico Caligaris‐Cappio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Caligaris‐Cappio. The network helps show where Federico Caligaris‐Cappio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Federico Caligaris‐Cappio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 38 | |
| 2 | 2019 | 13 | |
| 3 | 2017 | 63 | |
| 4 | 2017 | 15 | |
| 5 | 2016 | 20 | |
| 6 | INTERIM RESULTS FROM A PHASE IIA STUDY OF THE ANTI-CXCL12 SPIEGELMER OLAPTESED PEGOL (NOX-A12) IN COMBINATION WITH BENDAMUSTINE/RITUXIMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA | 2014 | 2 |
| 7 | 2014 | 3 | |
| 8 | 2012 | 37 | |
| 9 | 2012 | 17 | |
| 10 | 2011 | 62 | |
| 11 | 2010 | 40 | |
| 12 | 2009 | 1 | |
| 13 | 2008 | 4 | |
| 14 | 2004 | 47 | |
| 15 | 2000 | 4 | |
| 16 | 1999 | 2 | |
| 17 | 1999 | 31 | |
| 18 | 1997 | 19 | |
| 19 | 1992 | 29 | |
| 20 | MECCANISMI CELLULARI E MOLECOLARI CHE CONDIZIONANO L'ACCUMULO DI CELLULE NEOPLASTICHE RESTING NELLA LEUCEMIA LINFATICA CRONICA A B LINFOCITI (B-LLC) | 1991 | 1 |
About Federico Caligaris‐Cappio
Federico Caligaris‐Cappio is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine, having authored 211 papers that have together received 12.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (131 papers), Lymphoma Diagnosis and Treatment (68 papers), Immunodeficiency and Autoimmune Disorders (62 papers), Immune Cell Function and Interaction (37 papers), Monoclonal and Polyclonal Antibodies Research (25 papers), T-cell and B-cell Immunology (23 papers), Multiple Myeloma Research and Treatments (21 papers) and Peptidase Inhibition and Analysis (14 papers). The work is most often cited by research in Genetics (8.0k citations), Pathology and Forensic Medicine (5.4k citations) and Immunology (5.8k citations). Federico Caligaris‐Cappio has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Paolo Ghia, Michael J. Keating, Thomas J. Kipps, Michael Hallek, Emili Montserrat, Daniel Catovsky, Peter Hillmen, Cristina Scielzo, Bruce D. Cheson and Hartmut Döhner. Their work appears in journals such as The Lancet, Nucleic Acids Research and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.